<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37385286</PMID><DateCompleted><Year>2023</Year><Month>09</Month><Day>04</Day></DateCompleted><DateRevised><Year>2023</Year><Month>10</Month><Day>02</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2666-5247</ISSN><JournalIssue CitedMedium="Internet"><Volume>4</Volume><Issue>9</Issue><PubDate><Year>2023</Year><Month>Sep</Month></PubDate></JournalIssue><Title>The Lancet. Microbe</Title><ISOAbbreviation>Lancet Microbe</ISOAbbreviation></Journal><ArticleTitle>Viral persistence in children infected with SARS-CoV-2: current evidence and future research strategies.</ArticleTitle><Pagination><StartPage>e745</StartPage><EndPage>e756</EndPage><MedlinePgn>e745-e756</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/S2666-5247(23)00115-5</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S2666-5247(23)00115-5</ELocationID><Abstract><AbstractText>In this Personal View, we discuss current knowledge on SARS-CoV-2 RNA or antigen persistence in children infected with SARS-CoV-2. Based on the evidence that the virus can persist in adults, we have done a literature review and analysed studies that looked for SARS-CoV-2 RNA or antigens in children undergoing autopsy, biopsy, or surgery for either death from COVID-19 or multisystem inflammatory syndrome, or assessments for long COVID-19 or other conditions. Our analysis suggests that in children, independent from disease severity, SARS-CoV-2 can spread systemically and persist for weeks to months. We discuss what is known about the biological effects of viral persistence for other viral infections and highlight new scenarios for clinical, pharmacological, and basic research exploration. Such an approach will improve the understanding and management of post-viral syndromes.</AbstractText><CopyrightInformation>Copyright &#xa9; 2023 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY-NC-ND 4.0 license. Published by Elsevier Ltd.. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Buonsenso</LastName><ForeName>Danilo</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Woman and Child Health and Public Health, Fondazione Policlinico Universitario A Gemelli IRCCS, Rome, Italy; Centro di Salute Globale, Universit&#xe0; Cattolica del Sacro Cuore, Rome, Italy. Electronic address: danilo.buonsenso@policlinicogemelli.it.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Martino</LastName><ForeName>Laura</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Woman and Child Health and Public Health, Fondazione Policlinico Universitario A Gemelli IRCCS, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Morello</LastName><ForeName>Rosa</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Woman and Child Health and Public Health, Fondazione Policlinico Universitario A Gemelli IRCCS, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mariani</LastName><ForeName>Francesco</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Woman and Child Health and Public Health, Fondazione Policlinico Universitario A Gemelli IRCCS, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fearnley</LastName><ForeName>Kelly</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Bradford Royal Infirmary, West Yorkshire, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Valentini</LastName><ForeName>Piero</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Woman and Child Health and Public Health, Fondazione Policlinico Universitario A Gemelli IRCCS, Rome, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>06</Month><Day>26</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Lancet Microbe</MedlineTA><NlmUniqueID>101769019</NlmUniqueID><ISSNLinking>2666-5247</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D012367">RNA, Viral</NameOfSubstance></Chemical></ChemicalList><SupplMeshList><SupplMeshName Type="Disease" UI="C000705967">pediatric multisystem inflammatory disease, COVID-19 related</SupplMeshName></SupplMeshList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="Y">SARS-CoV-2</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012107" MajorTopicYN="N">Research Design</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012367" MajorTopicYN="N">RNA, Viral</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>Declaration of interests DB has received grants from Pfizer and Roche Italy to study long COVID in children. DB has participated in a peer-to-peer teaching programme on COVID-19 vaccines and long COVID in children, sponsored by Pfizer. All other authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>2</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>3</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>4</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>9</Month><Day>4</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>6</Month><Day>30</Day><Hour>1</Hour><Minute>6</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>6</Month><Day>29</Day><Hour>18</Hour><Minute>52</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>6</Month><Day>26</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37385286</ArticleId><ArticleId IdType="pmc">PMC10292824</ArticleId><ArticleId IdType="doi">10.1016/S2666-5247(23)00115-5</ArticleId><ArticleId IdType="pii">S2666-5247(23)00115-5</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>WHO  A clinical case definition of post COVID-19 condition by a Delphi consensus. 2021. https://www.who.int/publications/i/item/WHO-2019-nCoV-Post_COVID-19_condition-Clinical_case_definition-2021.1</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8691845</ArticleId><ArticleId IdType="pubmed">34951953</ArticleId></ArticleIdList></Reference><Reference><Citation>WHO  A clinical case definition for post COVID-19 condition in children and adolescents by expert consensus. 2023. https://www.who.int/publications/i/item/WHO-2019-nCoV-Post-COVID-19-condition-CA-Clinical-case-definition-2023-1</Citation></Reference><Reference><Citation>Davis HE, McCorkell L, Vogel JM, Topol EJ. Long COVID: major findings, mechanisms and recommendations. Nat Rev Microbiol. 2023;21:133&#x2013;146.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9839201</ArticleId><ArticleId IdType="pubmed">36639608</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhatnagar J, Gary J, Regan-Steiner S, et al. Evidence of severe acute respiratory syndrome coronavirus 2 replication and tropism in the lungs, airways, and vascular endothelium of patients with fatal coronavirus disease 2019: an autopsy case series. J Infect Dis. 2021;223:752&#x2013;764.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7928839</ArticleId><ArticleId IdType="pubmed">33502471</ArticleId></ArticleIdList></Reference><Reference><Citation>Dorward DA, Russel CD, Un IH, et al. Tissue-specific immunopathology in fatal COVID-19. Am J Respir Crit Care Med. 2021;203:192&#x2013;201.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7874430</ArticleId><ArticleId IdType="pubmed">33217246</ArticleId></ArticleIdList></Reference><Reference><Citation>Schurink B, Roos E, Radonic T, et al. Viral presence and immunopathology in patients with lethal COVID-19: a prospective autopsy cohort study. Lancet Microbe. 2020;1:e290&#x2013;e299.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7518879</ArticleId><ArticleId IdType="pubmed">33015653</ArticleId></ArticleIdList></Reference><Reference><Citation>Varga Z, Flammer AJ, Steiger P, et al. Endothelial cell infection and endotheliitis in COVID-19. Lancet. 2020;395:1417&#x2013;1418.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7172722</ArticleId><ArticleId IdType="pubmed">32325026</ArticleId></ArticleIdList></Reference><Reference><Citation>Stein SR, Ramelli SC, Grazioli A, et al. SARS-CoV-2 infection and persistence in the human body and brain at autopsy. Nature. 2022;612:758&#x2013;763.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9749650</ArticleId><ArticleId IdType="pubmed">36517603</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Cleemput J, van Snippenberg W, Lambrechts L, et al. Organ-specific genome diversity of replication-competent SARS-CoV-2. Nat Commun. 2021;12</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8595628</ArticleId><ArticleId IdType="pubmed">34785663</ArticleId></ArticleIdList></Reference><Reference><Citation>Gaebler C, Wang Z, Lorenzi JCC, et al. Evolution of antibody immunity to SARS-CoV-2. Nature. 2021;591:639&#x2013;644.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8221082</ArticleId><ArticleId IdType="pubmed">33461210</ArticleId></ArticleIdList></Reference><Reference><Citation>Ceulemans LJ, Khan M, Yoo S-J, et al. Persistence of SARS-CoV-2 RNA in lung tissue after mild COVID-19. Lancet Respir Med. 2021;9:e78&#x2013;e79.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8189667</ArticleId><ArticleId IdType="pubmed">34118186</ArticleId></ArticleIdList></Reference><Reference><Citation>Goh D, Lim JCT, Ferna&#x131;ndez SB, et al. Case report: persistence of residual antigen and RNA of the SARS-CoV-2 virus in tissues of two patients with long COVID. Front Immunol. 2022;13</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9483160</ArticleId><ArticleId IdType="pubmed">36131932</ArticleId></ArticleIdList></Reference><Reference><Citation>Schulthei&#xdf; C, Willscher E, Paschold L, et al. Liquid biomarkers of macrophage dysregulation and circulating spike protein illustrate the biological heterogeneity in patients with post-acute sequelae of COVID-19. J Med Virol. 2023;95</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9878213</ArticleId><ArticleId IdType="pubmed">36458566</ArticleId></ArticleIdList></Reference><Reference><Citation>Hettle D, Hutchings S, Muir P, Moran E. Persistent SARS-CoV-2 infection in immunocompromised patients facilitates rapid viral evolution: retrospective cohort study and literature review. Clin Infect Pract. 2022;16</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9666269</ArticleId><ArticleId IdType="pubmed">36405361</ArticleId></ArticleIdList></Reference><Reference><Citation>Rutkai I, Mayer MG, Hellmers LM, et al. Neuropathology and virus in brain of SARS-CoV-2 infected non-human primates. Nat Commun. 2022;13</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8975902</ArticleId><ArticleId IdType="pubmed">35365631</ArticleId></ArticleIdList></Reference><Reference><Citation>Morioka S, Tsuzuki S, Suzuki M, et al. Post COVID-19 condition of the Omicron variant of SARS-CoV-2. J Infect Chemother. 2022;28:1546&#x2013;1551.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9365517</ArticleId><ArticleId IdType="pubmed">35963600</ArticleId></ArticleIdList></Reference><Reference><Citation>Taquet M, Sillett R, Zhu L, et al. Neurological and psychiatric risk trajectories after SARS-CoV-2 infection: an analysis of 2-year retrospective cohort studies including 1&#x2008;284&#x2008;437 patients. Lancet Psychiatry. 2022;9:815&#x2013;827.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9385200</ArticleId><ArticleId IdType="pubmed">35987197</ArticleId></ArticleIdList></Reference><Reference><Citation>Magnusson K, Kristoffersen DT, Dell'Isola A, et al. Post-covid medical complaints following infection with SARS-CoV-2 Omicron vs Delta variants. Nat Commun. 2022;13</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9709355</ArticleId><ArticleId IdType="pubmed">36450749</ArticleId></ArticleIdList></Reference><Reference><Citation>Gomes I, Karmirian K, Oliveira JT, et al. SARS-CoV-2 infection of the central nervous system in a 14-month-old child: a case report of a complete autopsy. Lancet Reg Health Am. 2021;2</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8397543</ArticleId><ArticleId IdType="pubmed">34485969</ArticleId></ArticleIdList></Reference><Reference><Citation>Poisson KE, Zygmunt A, Leino D, et al. Lethal pediatric cerebral vasculitis triggered by severe acute respiratory syndrome coronavirus 2. Pediatr Neurol. 2022;127:1&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8585961</ArticleId><ArticleId IdType="pubmed">34864371</ArticleId></ArticleIdList></Reference><Reference><Citation>Mabena FC, Baillie VL, Hale MJ, et al. Clinical characteristics and histopathology of coronavirus disease 2019&#x2013;related deaths in African children. Pediatr Infect Dis J. 2021;40:e323&#x2013;e332.</Citation><ArticleIdList><ArticleId IdType="pubmed">34397776</ArticleId></ArticleIdList></Reference><Reference><Citation>Freij BJ, Gebara BM, Tariq R, et al. Fatal central nervous system co-infection with SARS-CoV-2 and tuberculosis in a healthy child. BMC Pediatr. 2020;20:429.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7479402</ArticleId><ArticleId IdType="pubmed">32907595</ArticleId></ArticleIdList></Reference><Reference><Citation>Menger J, Apostolidou S, Edler C, et al. Fatal outcome of SARS-CoV-2 infection (B1.1.7) in a 4-year-old child. Int J Legal Med. 2022;136:189&#x2013;192.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8435154</ArticleId><ArticleId IdType="pubmed">34510268</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhatnagar J, Gary J, Reagan-Steiner S, et al. Evidence of severe acute respiratory syndrome coronavirus 2 replication and tropism in the lungs, airways, and vascular endothelium of patients with fatal coronavirus disease 2019: an autopsy case series. J Infect Dis. 2021;223:752&#x2013;764.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7928839</ArticleId><ArticleId IdType="pubmed">33502471</ArticleId></ArticleIdList></Reference><Reference><Citation>Ninan S, Thompson P, Gershon T, et al. Fatal pediatric COVID-19 case with seizures and fulminant cerebral edema. Child Neurol Open. 2021;8 2329048X21102253.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8207268</ArticleId><ArticleId IdType="pubmed">34179214</ArticleId></ArticleIdList></Reference><Reference><Citation>Duarte-Neto AN, Caldini E, Gomes-Gouvea MS, et al. An autopsy study of the spectrum of severe COVID-19 in children: from SARS to different phenotypes of MIS-C. EClinicalMedicine. 2021;35</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8072136</ArticleId><ArticleId IdType="pubmed">33937731</ArticleId></ArticleIdList></Reference><Reference><Citation>Taweevisit M, Chindamporn A, Sujjavorakul K, Samransamruajkit R, Thorner PS. Multisystem inflammatory syndrome in children (MIS-C) showing disseminated aspergillosis, cytomegalovirus reactivation and persistent SARS-CoV-2: case report with autopsy review. Pathol Res Pract. 2022;238</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9443656</ArticleId><ArticleId IdType="pubmed">36087417</ArticleId></ArticleIdList></Reference><Reference><Citation>Dolhnikoff M, Ferreira Ferranti J, de Almeida Monteiro RA, et al. SARS-CoV-2 in cardiac tissue of a child with COVID-19-related multisystem inflammatory syndrome. Lancet Child Adolesc Health. 2020;4:790&#x2013;794.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7440866</ArticleId><ArticleId IdType="pubmed">32828177</ArticleId></ArticleIdList></Reference><Reference><Citation>Mayordomo-Colunga J, Vivanco-Allende A, Lopez-Alonso S, et al. SARS-CoV-2 spike protein in intestinal cells of a patient with coronavirus disease 2019 multisystem inflammatory syndrome. J Pediatr. 2022;243:214&#x2013;18e215.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8626144</ArticleId><ArticleId IdType="pubmed">34843710</ArticleId></ArticleIdList></Reference><Reference><Citation>Sigal GB, Novak T, Mathew A, et al. Overcoming COVID-19 investigators. Measurement of severe acute respiratory syndrome coronavirus 2 antigens in plasma of pediatric patients with acute coronavirus disease 2019 or multisystem inflammatory syndrome in children using an ultrasensitive and quantitative immunoassay. Clin Infect Dis. 2022;75:1351&#x2013;1358.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8903440</ArticleId><ArticleId IdType="pubmed">35213684</ArticleId></ArticleIdList></Reference><Reference><Citation>Arostegui D, Castro K, Schwarz S, Vaidy K, Rabinowitz S, Wallach T. Persistent SARS-CoV-2 nucleocapsid protein presence in the intestinal epithelium of a pediatric patient 3 months after acute infection. JPGN Reports. 2022;3:e152.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10158423</ArticleId><ArticleId IdType="pubmed">37168753</ArticleId></ArticleIdList></Reference><Reference><Citation>Scottoni F, Giobbe GG, Zambaiti E, et al. Intussusception and COVID-19 in infants: evidence for an etiopathologic correlation. Pediatrics. 2022;149</Citation><ArticleIdList><ArticleId IdType="pubmed">35322271</ArticleId></ArticleIdList></Reference><Reference><Citation>Colmenero I, Santonja C, Alonso-Ria&#xf1;o M, et al. SARS-CoV-2 endothelial infection causes COVID-19 chilblains: histopathological, immunohistochemical and ultrastructural study of seven paediatric cases. Br J Dermatol. 2020;183:729&#x2013;737.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7323219</ArticleId><ArticleId IdType="pubmed">32562567</ArticleId></ArticleIdList></Reference><Reference><Citation>Ara&#xfa;jo NM, Ferreira LC, Dantas DP, et al. First report of SARS-CoV-2 detection in cerebrospinal fluid in a child with Guillain-Barr&#xe9; syndrome. Pediatr Infect Dis J. 2021;40:e274&#x2013;e276.</Citation><ArticleIdList><ArticleId IdType="pubmed">33990525</ArticleId></ArticleIdList></Reference><Reference><Citation>Miura CS, Lima TM, Martins RB, et al. Asymptomatic SARS-CoV-2 infection in children's tonsils. Rev Bras Otorrinolaringol. 2022;88:9.</Citation></Reference><Reference><Citation>Xu Q, Milanez-Almeida P, Martins AJ, et al. Adaptive immune responses to SARS-CoV-2 persist in the pharyngeal lymphoid tissue of children. Nat Immunol. 2023;24:186&#x2013;199.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10777159</ArticleId><ArticleId IdType="pubmed">36536106</ArticleId></ArticleIdList></Reference><Reference><Citation>Schwartz DA, Avvad-Portari E, Bab&#xe1;l P, et al. placental tissue destruction and insufficiency from COVID-19 causes stillbirth and neonatal death from hypoxic-ischemic injury. Arch Pathol Lab Med. 2022;146:660&#x2013;676.</Citation><ArticleIdList><ArticleId IdType="pubmed">35142798</ArticleId></ArticleIdList></Reference><Reference><Citation>Lesieur E, Torrents J, Fina F, et al. Congenital infection of severe acute respiratory syndrome coronavirus 2 with intrauterine fetal death: a clinicopathological study with molecular analysis. Clin Infect Dis. 2022;75:e1092&#x2013;e1100.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8500004</ArticleId><ArticleId IdType="pubmed">34553751</ArticleId></ArticleIdList></Reference><Reference><Citation>Reagan-Steiner S, Bhatnagar J, Martines RB, et al. Detection of SARS-CoV-2 in neonatal autopsy tissues and placenta. Emerg Infect Dis. 2022;28:510&#x2013;517.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8888232</ArticleId><ArticleId IdType="pubmed">35138244</ArticleId></ArticleIdList></Reference><Reference><Citation>He R, Hou S, Liu C, et al. Follicular CXCR5-expressing CD8+ T cells curtail chronic viral infection. Nature. 2016;537:412&#x2013;416.</Citation><ArticleIdList><ArticleId IdType="pubmed">27501245</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu D, Ye L. A portrait of CXCR5+ follicular cytotoxic CD8+ T cells. Trends Immunol. 2018;39:965&#x2013;979.</Citation><ArticleIdList><ArticleId IdType="pubmed">30377045</ArticleId></ArticleIdList></Reference><Reference><Citation>Focosi D, Bestagno M, Burrone O, Petrini M. CD57+ T lymphocytes and functional immune deficiency. J Leukoc Biol. 2010;87:107&#x2013;116.</Citation><ArticleIdList><ArticleId IdType="pubmed">19880576</ArticleId></ArticleIdList></Reference><Reference><Citation>Percivalle E, Sammartino JC, Cassaniti I, et al. Macrophages and monocytes: &#x201c;Trojan Horses&#x201d; in COVID-19. Viruses. 2021;13</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8624282</ArticleId><ArticleId IdType="pubmed">34834984</ArticleId></ArticleIdList></Reference><Reference><Citation>Matveeva O, Nechipurenko Y, Lagutkin D, Yegorov YE, Kzhyshkowska J. SARS-CoV-2 infection of phagocytic immune cells and COVID-19 pathology: antibody-dependent as well as independent cell entry. Front Immunol. 2022;13</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9751203</ArticleId><ArticleId IdType="pubmed">36532011</ArticleId></ArticleIdList></Reference><Reference><Citation>Patterson BK, Francisco EB, Yogendra R, et al. Persistence of SARS-CoV-2 S1 protein in CD16+ monocytes in post-acute sequelae of COVID-19 (PASC) up to 15 months post-infection. Front Immunol. 2022;12</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8784688</ArticleId><ArticleId IdType="pubmed">35082777</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim TS, Hufford MM, Sun J, Fu YX, Braciale TJ. Antigen persistence and the control of local T cell memory by migrant respiratory dendritic cells after acute virus infection. J Exp Med. 2010;207:1161&#x2013;1172.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2882836</ArticleId><ArticleId IdType="pubmed">20513748</ArticleId></ArticleIdList></Reference><Reference><Citation>Newell KL, Waickman AT. Inflammation, immunity, and antigen persistence in post-acute sequelae of SARS-CoV-2 infection. Curr Opin Immunol. 2022;77</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9127180</ArticleId><ArticleId IdType="pubmed">35724449</ArticleId></ArticleIdList></Reference><Reference><Citation>Peluso MJ, Lu S, Tang AF, et al. Markers of immune activation and inflammation in individuals with postacute sequelae of severe acute respiratory syndrome coronavirus 2 infection. J Infect Dis. 2021;224:1839&#x2013;1848.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8643408</ArticleId><ArticleId IdType="pubmed">34677601</ArticleId></ArticleIdList></Reference><Reference><Citation>Phetsouphanh C, Darley DR, Wilson DB, et al. Immunological dysfunction persists for 8 months following initial mild-to-moderate SARS-CoV-2 infection. Nat Immunol. 2022;23:210&#x2013;216.</Citation><ArticleIdList><ArticleId IdType="pubmed">35027728</ArticleId></ArticleIdList></Reference><Reference><Citation>Patterson BK, Guevara-Coto J, Yogendra R, et al. Immune-based prediction of COVID-19 severity and chronicity decoded using machine learning. Front Immunol. 2021;12</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8273732</ArticleId><ArticleId IdType="pubmed">34262570</ArticleId></ArticleIdList></Reference><Reference><Citation>Son K, Jamil R, Chowdhury A, et al. Circulating anti-nuclear autoantibodies in COVID-19 survivors predict long COVID symptoms. Eur Respir J. 2023;61</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9515477</ArticleId><ArticleId IdType="pubmed">36137590</ArticleId></ArticleIdList></Reference><Reference><Citation>Poon MML, Rybkina K, Kato Y, et al. SARS-CoV-2 infection generates tissue-localized immunological memory in humans. Sci Immunol. 2021;6</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8626868</ArticleId><ArticleId IdType="pubmed">34618554</ArticleId></ArticleIdList></Reference><Reference><Citation>Chioh FW, Fong S-W, Young BE, et al. Convalescent COVID-19 patients are susceptible to endothelial dysfunction due to persistent immune activation. eLife. 2021;10</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7987341</ArticleId><ArticleId IdType="pubmed">33752798</ArticleId></ArticleIdList></Reference><Reference><Citation>Kruger A, Vlok M, Turner S, et al. Proteomics of fibrin amyloid microclots in long COVID/post-acute sequelae of COVID-19 (PASC) shows many entrapped pro-inflammatory molecules that may also contribute to a failed fibrinolytic system. Cardiovasc Diabetol. 2022;21:190.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9491257</ArticleId><ArticleId IdType="pubmed">36131342</ArticleId></ArticleIdList></Reference><Reference><Citation>Hirschenberger M, Hunszinger V, Sparrer KMJ. Implications of innate immunity in post-acute sequelae of non-persistent viral infections. Cells. 2021;10</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8391718</ArticleId><ArticleId IdType="pubmed">34440903</ArticleId></ArticleIdList></Reference><Reference><Citation>Buonsenso D, Valentini P, De Rose C, et al. Recovering or persisting: the immunopathological features of SARS-CoV-2 infection in children. J Clin Med. 2022;11</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9369242</ArticleId><ArticleId IdType="pubmed">35955979</ArticleId></ArticleIdList></Reference><Reference><Citation>Boribong BP, LaSalle TJ, Bartsch YC, et al. Neutrophil profiles of pediatric COVID-19 and multisystem inflammatory syndrome in children. Cell Rep Med. 2022;3</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9676175</ArticleId><ArticleId IdType="pubmed">36476388</ArticleId></ArticleIdList></Reference><Reference><Citation>Bline K, Andrews A, Moore-Clingenpeel M, et al. Myeloid-derived suppressor cells and clinical outcomes in children with COVID-19. Front Pediatr. 2022;10</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9207271</ArticleId><ArticleId IdType="pubmed">35733812</ArticleId></ArticleIdList></Reference><Reference><Citation>Koushki K, Salemi M, Miri SM, Arjeini Y, Keshavarz M, Ghaemi A. Role of myeloid-derived suppressor cells in viral respiratory infections; hints for discovering therapeutic targets for COVID-19. Biomed Pharmacother. 2021;144</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8516725</ArticleId><ArticleId IdType="pubmed">34678727</ArticleId></ArticleIdList></Reference><Reference><Citation>Siemi&#x144;ska I, W&#x119;glarczyk K, Surmiak M, et al. Mild and asymptomatic COVID-19 convalescents present long-term endotype of immunosuppression associated with neutrophil subsets possessing regulatory functions. Front Immunol. 2021;12</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8511487</ArticleId><ArticleId IdType="pubmed">34659245</ArticleId></ArticleIdList></Reference><Reference><Citation>Kendall EK, Olaker VR, Kaelber DC, Xu R, Davis PB. Association of SARS-CoV-2 infection with new-onset type 1 diabetes among pediatric patients from 2020 to 2021. JAMA Netw Open. 2022;5</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9508649</ArticleId><ArticleId IdType="pubmed">36149658</ArticleId></ArticleIdList></Reference><Reference><Citation>Owen DR, Allerton CMN, Anderson AS, et al. An oral SARS-CoV-2 Mpro inhibitor clinical candidate for the treatment of COVID-19. Science. 2021;374:1586&#x2013;1593.</Citation><ArticleIdList><ArticleId IdType="pubmed">34726479</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie Y, Choi T, Al-Aly Z. Association of treatment with nirmatrelvir and the risk of post-COVID-19 condition. JAMA Intern Med. 2023</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10037200</ArticleId><ArticleId IdType="pubmed">36951829</ArticleId></ArticleIdList></Reference><Reference><Citation>Peluso MJ, Anglin K, Durstenfeld MS, et al. Effect of oral nirmatrelvir on long COVID symptoms: 4 cases and rationale for systematic studies. Pathog Immun. 2022;7:95&#x2013;103.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9254867</ArticleId><ArticleId IdType="pubmed">35800257</ArticleId></ArticleIdList></Reference><Reference><Citation>Goel N, Goyal N, Nagaraja R, Kumar R. Systemic corticosteroids for management of &#x2018;long-COVID&#x2019;: an evaluation after 3 months of treatment. Monaldi Arch Chest Dis. 2021;92</Citation><ArticleIdList><ArticleId IdType="pubmed">34730322</ArticleId></ArticleIdList></Reference><Reference><Citation>Thompson JS, Thornton AC, Ainger T, Garvy BA. Long-term high-dose immunoglobulin successfully treats Long COVID patients with pulmonary, neurologic, and cardiologic symptoms. Front Immunol. 2023;13</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9932260</ArticleId><ArticleId IdType="pubmed">36818469</ArticleId></ArticleIdList></Reference><Reference><Citation>Byambasuren O, Stehlik P, Clark J, Alcorn K, Glasziou P. Effect of covid-19 vaccination on long covid: systematic review. BMJ Med. 2023;2</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9978692</ArticleId><ArticleId IdType="pubmed">36936268</ArticleId></ArticleIdList></Reference><Reference><Citation>Morello R, De Rose C, Cardinali S, Valentini P, Buonsenso D. Lactoferrin as possible treatment for chronic gastrointestinal symptoms in children with long COVID: case series and literature review. Children. 2022;9</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9600357</ArticleId><ArticleId IdType="pubmed">36291381</ArticleId></ArticleIdList></Reference><Reference><Citation>Parodi E, Carpino A, Franchitti E, et al. Detection of faecal SARS-CoV-2 RNA in a prospective cohort of children with multisystem inflammatory syndrome (MIS-C) Epidemiol Prev. 2021;45:522&#x2013;527.</Citation><ArticleIdList><ArticleId IdType="pubmed">34841834</ArticleId></ArticleIdList></Reference><Reference><Citation>Choutka J, Jansari V, Hornig M, Iwasaki A. Unexplained post-acute infection syndromes. Nat Med. 2022;28:911&#x2013;923.</Citation><ArticleIdList><ArticleId IdType="pubmed">35585196</ArticleId></ArticleIdList></Reference><Reference><Citation>Yao XP, Ye J, Feng T, et al. Adaptor protein MyD88 confers the susceptibility to stress via amplifying immune danger signals. Brain Behav Immun. 2023;108:204&#x2013;220.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9726649</ArticleId><ArticleId IdType="pubmed">36496170</ArticleId></ArticleIdList></Reference><Reference><Citation>Griffin DE. Measles virus persistence and its consequences. Curr Opin Virol. 2020;41:46&#x2013;51.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7492426</ArticleId><ArticleId IdType="pubmed">32387998</ArticleId></ArticleIdList></Reference><Reference><Citation>Cocciolillo F, Di Giuda D, Morello R, De Rose C, Valentini P, Buonsenso D. Orbito-frontal cortex hypometabolism in children with post-COVID condition (long COVID): a preliminary experience. Pediatr Infect Dis J. 2022;41:663&#x2013;665.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9281418</ArticleId><ArticleId IdType="pubmed">35839175</ArticleId></ArticleIdList></Reference><Reference><Citation>Griffin DE. Why does viral RNA sometimes persist after recovery from acute infections? PLoS Biol. 2022;20</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9191737</ArticleId><ArticleId IdType="pubmed">35648781</ArticleId></ArticleIdList></Reference><Reference><Citation>Fawzy NA, Shaar BA, Taha R, et al. A systematic review of trials currently investigating therapeutic modalities for post-acute COVID-19 syndrome and registered on World Health Organization international clinical trials platform. Clin Microbiol Infect. 2023;29:570&#x2013;577.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9837206</ArticleId><ArticleId IdType="pubmed">36642173</ArticleId></ArticleIdList></Reference><Reference><Citation>Soldan SS, Lieberman PM. Epstein-Barr virus and multiple sclerosis. Nat Rev Microbiol. 2023;21:51&#x2013;64.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9362539</ArticleId><ArticleId IdType="pubmed">35931816</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>